Literature DB >> 11029986

Strategies to eradicate rubella in the English-speaking Caribbean.

B Irons1, M J Lewis, M Dahl-Regis, C Castillo-Solórzano, P A Carrasco, C A de Quadros.   

Abstract

OBJECTIVE: This report presents the strategies used to eradicate rubella in the Caribbean region and the challenges faced by that effort.
METHODS: Using the surveillance system for measles cases that was instituted in all countries in the Caribbean Community (CARICOM), 12 countries confirmed cases of rubella between 1992 and 1996. Rubella infections occurred in epidemic proportions in 6 countries during that period.
RESULTS: On the basis of the rubella prevalence data, rubella-congenital rubella syndrome (CRS) cost-benefit analysis, and cost-effectiveness of the mass campaign, the Council for Human and Social Development of CARICOM resolved, on April 21, 1998, that every effort would be made to eradicate rubella, as well as to prevent the occurrence of new cases of CRS by the end of 2000. Using the Pan American Health Organization's template for measles eradication, CARICOM proposed and implemented the main strategies for rubella and CRS eradication, and rubella mass campaigns were conducted in 18 countries. The target population, which included males and females (aged 20-40 years), was approximately 2.2 million.
CONCLUSION: The major challenges for rubella eradication are attaining high vaccine coverage in the adult population and maintaining an effective surveillance system able to detect rubella activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11029986      PMCID: PMC1446383          DOI: 10.2105/ajph.90.10.1545

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  4 in total

1.  Neonatal manifestation of congenital rubella following an outbreak in Trinidad.

Authors:  Z Ali; B Hull; M Lewis
Journal:  J Trop Pediatr       Date:  1986-04       Impact factor: 1.165

Review 2.  Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 1: Burden of disease from CRS.

Authors:  F T Cutts; S E Robertson; J L Diaz-Ortega; R Samuel
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

3.  Rational strategy for rubella vaccination.

Authors:  A R Hinman; K J Bart; W A Orenstein; S R Preblud
Journal:  Lancet       Date:  1983-01-01       Impact factor: 79.321

4.  WHO collaborative study on the sero-epidemiology of rubella in Caribbean and Middle and South American populations in 1968.

Authors:  W R Dowdle; W Ferrera; L F De Salles Gomes; D King; M Kourany; J Madalengoitia; E Pearson; W H Swanston; H C Tosi; A M Vilches
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

  4 in total
  5 in total

1.  Identification of Serologic Markers for School-Aged Children With Congenital Rubella Syndrome.

Authors:  Terri B Hyde; Helena Keico Sato; LiJuan Hao; Brendan Flannery; Qi Zheng; Kathleen Wannemuehler; Flávia Helena Ciccone; Heloisa de Sousa Marques; Lily Yin Weckx; Marco Aurélio Sáfadi; Eliane de Oliveira Moraes; Marisa Mussi Pinhata; Jaime Olbrich Neto; Maria Cecilia Bevilacqua; Alfredo Tabith Junior; Tatiana Alves Monteiro; Cristina Adelaide Figueiredo; Jon K Andrus; Susan E Reef; Cristiana M Toscano; Carlos Castillo-Solorzano; Joseph P Icenogle
Journal:  J Infect Dis       Date:  2014-10-31       Impact factor: 5.226

Review 2.  Health economics of rubella: a systematic review to assess the value of rubella vaccination.

Authors:  Joseph B Babigumira; Ian Morgan; Ann Levin
Journal:  BMC Public Health       Date:  2013-04-29       Impact factor: 3.295

3.  [The role of long-acting release (LAR) depot octreotide as adjuvant management of short bowel disease].

Authors:  Efraín Gómez-Herrera; Oscar Alejandro Farías-Llamas; José Luis Gutiérrez-de la Rosa; José Manuel Hermosillo-Sandoval
Journal:  Cir Cir       Date:  2004 Sep-Oct       Impact factor: 0.361

4.  Rubella natural immunity among adolescent girls in Tanzania: the need to vaccinate child bearing aged women.

Authors:  Mariam M Mirambo; Mtebe Majigo; Seth D Scana; Martha F Mushi; Said Aboud; Uwe Groß; Benson R Kidenya; Stephen E Mshana
Journal:  BMC Womens Health       Date:  2018-01-03       Impact factor: 2.809

5.  Lack of immunity against rubella among Italian young adults.

Authors:  Maria Serena Gallone; Cinzia Germinario
Journal:  BMC Infect Dis       Date:  2017-03-07       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.